In recent years, liver experts have conducted in-depth discussions on whether it is
necessary to expand the indication of antiviral therapy for patients with chronic hepatitis B …

Objective To evaluate medication adherence among patients with hepatitis B-related
cirrhosis who developed decompensation and mortality, and to examine the association …

Elevated serum gamma‐glutamyl transferase (GGT) levels are associated with chronic
hepatitis B (CHB)‐related hepatocellular carcinoma. However, their role in predicting …

Background: Air pollution is a risk factor for hepatocellular carcinoma (HCC). However, the
effect of air pollution on HCC risk in patients with hepatitis remains unclear. Methods: This …

Background The biochemical response is a crucial indicator of prognosis in chronic hepatitis
B (CHB) patients treated with nucleotide/nucleoside analogues (NAs). The impact of …

Hepatitis B reactivation is a common complication in lymphoma patients under
immunosuppressive treatment with potentially serious and life-threating consequences. In …

Cardiac lipomas are generally asymptomatic even in large dimensions. Echocardiograms
can identify tumors, but cardiac magnetic resonance imaging or cardiac computerized …

Unawareness of hepatitis B virus (HBV) infection and lack of surveillance may serve as
major barriers to HBV control and contributors to severe hepatocellular carcinoma (HCC) at …

Chronic hepatitis B (CHB) continues to contribute to worldwide morbidity and mortality
significantly. Scientists, clinicians, pharmaceutical companies, and health organizations …

Hepatitis B virus (HBV)-related liver cirrhosis (HBV-LC) presents a substantial mortality and
hepatocellular carcinoma (HCC) risk. While antiviral therapy (AVT) is the standard, complete …